
FDA launches full nutrient review of infant formula in 27 years; NIH finds breast tissue biomarker that could flag cancer; most Americans trust the MMR vaccine, not Trump’s handling of measles outbreak – Morning Medical Update
Key Takeaways
- The FDA and HHS are reviewing infant formula nutrient guidelines, seeking public and scientific input for potential updates.
- NIH researchers identified stromal disruption as a potential biomarker for predicting breast cancer risk, offering new screening opportunities.
The top news stories today.
As part of Operation Stork Speed, the Food and Drug Administration (FDA) and Health and Human Services (HHS) are giving
National Institutes of Health (NIH) researchers have identified a new potential biomarker — called stromal disruption — that could
With the largest U.S. measles outbreak in 25 years underway, a new
Related to this article









